← boothcheck

Is AZN overvalued?

boothcheck doesn't label AZN overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, AZN is priced for growth of +21.0%, and an operating margin near 8.3% versus the 18.7% it earns today. The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price. The more the price assumes beyond what ASTRAZENECA PLC has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from ASTRAZENECA PLC's SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth+21.0%
For about
Margin needed8.3%
Margin today18.7%
Price vs asset value2.38x
Price vs earnings power2.53x
Price vs peer multiples1.13x
Price vs forward growth0.82x
Read the full AZN report →
Get boothcheck's read on what AZN's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.